Radius Health, Inc. (RDUS)

38.18
NASDAQ
Prev Close 37.29
Day Low/High 37.38 / 38.61
52 Wk Low/High 28.00 / 59.88
Exchange NASDAQ
Shares Outstanding 43.19B
Market Cap 1.61B
Div & Yield N.A. (N.A)

Latest News

Radius Health Receives Notification Of PDUFA Extension For Abaloparatide-SC

Radius Health Receives Notification Of PDUFA Extension For Abaloparatide-SC

PDUFA goal date extended by standard extension period of three months to June 30, 2017

Interesting RDUS Put And Call Options For March 17th

Interesting RDUS Put And Call Options For March 17th

Investors in Radius Health Inc saw new options become available this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

'Mad Money' Lightning Round: Take Citi Over CIT Group

'Mad Money' Lightning Round: Take Citi Over CIT Group

Cramer says P&G is a good choice and is disappointed by Bristol-Myers Squibb.

Jim Cramer's 'Mad Money' Recap: Here's What's Ailing This Market

Jim Cramer's 'Mad Money' Recap: Here's What's Ailing This Market

A malaise has once again befallen America, Cramer says.

Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad

Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad

Why Trump is killing biotech stocks, the Shire-for-Radius rumor makes no sense and Bernie Sanders gets a tweeting lesson.

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO

Cramer is avoiding TPC Composites and is lukewarm on Kinder Morgan.

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game

Consistency and discipline are two values this market has sorely lacked in 2016, Cramer says.

Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health

Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health

Cramers is avoiding Nike and loves Newell so much he bought the company for Action Alerts PLUS.

Jim Cramer's 'Mad Money' Recap: Don't Touch These 'Third Rail' Stocks

Jim Cramer's 'Mad Money' Recap: Don't Touch These 'Third Rail' Stocks

The stocks we thought would be the strongest in 2016 are now losing their footing, Cramer says.

Radius Announces Publication Of Additional Positive Results From The Phase 3 ACTIVE Trial Of Abaloparatide-SC In JBMR

Radius Announces Publication Of Additional Positive Results From The Phase 3 ACTIVE Trial Of Abaloparatide-SC In JBMR

Results show consistency of Abaloparatide-SC responses across a wide range of patient subgroups

Short Interest Increases 11.4% For RDUS

Short Interest Increases 11.4% For RDUS

The most recent short interest data has been released for the 08/31/2016 settlement date, which shows a 739,137 share increase in total short interest for Radius Health Inc , to 7,245,291, an increase of 11.36% since 08/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

These 5 Stocks Are Poised for Big Breakouts

These 5 Stocks Are Poised for Big Breakouts

Here's a technical look at how to trade five stocks within range of triggering big breakouts.

Radius Health Announces Three Presentations On RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016

Radius Health Announces Three Presentations On RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016

SABCS to include three abstracts from the development program for RAD1901 as a potential treatment of ER-positive advanced breast cancer

JAMA Publishes Positive Phase 3 Data For Abaloparatide In Postmenopausal Women With Osteoporosis

JAMA Publishes Positive Phase 3 Data For Abaloparatide In Postmenopausal Women With Osteoporosis

Results from Phase 3 ACTIVE trial show abaloparatide significantly reduced the incidence of new vertebral fractures and nonvertebral fractures in postmenopausal women with osteoporosis at 18 months when compared with placebo

Overboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A

Overboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A

Board members who sit on four or more boards may find it impossible to manage their time when faced with an insurgent investor or merger situation -- or both.

Radius Health, Subject of Takeover Talk, Rises Again

Radius Health, Subject of Takeover Talk, Rises Again

The drug maker with an osteoporosis product in development has been speculated about as a consolidation candidate.